Clinical Trials Directory

Trials / Unknown

UnknownNCT05672498

Effect of a Traditional Chinese Medicine Formulation on COVID-19 Infection

A Comparative Study on the Therapeutic Effect of a Traditional Chinese Medicine Formulation on COVID-19 Infection

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (estimated)
Sponsor
First Affiliated Hospital Xi'an Jiaotong University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Traditional Chinese medicine (TCM) has been handed down for thousands of years. It has a long history in the treatment of virus infection and has a good effect on the upper respiratory tract infection. In recent years, the project applicant has been conducting research on the anti infection and anti inflammation treatment of traditional Chinese medicine, and has carried out a lot of clinical practice exploration in non-specific inflammation. The purpose of this research is to study the therapeutic effect of a traditional Chinese medicine prescription on COVID-19 infection.

Conditions

Interventions

TypeNameDescription
DRUGTraditional Chinese Medicine FormulationThe TCM Treatment Group:The patient are given a traditional Chinese medicine formulation, taking 150 ml of liquid medicine every morning and evening for 7 days.
OTHERPlacebo TreatmentPlacebo Treatment Group:The patient are given placebo, taking 150 ml of liquid placebo every morning and evening for 7 days. All medications and placebo are packed identically in packing bags with the same labeling form.

Timeline

Start date
2023-01-05
Primary completion
2023-04-05
Completion
2023-05-05
First posted
2023-01-05
Last updated
2023-01-09

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05672498. Inclusion in this directory is not an endorsement.